CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...
Phase 2
McKinney, Texas, United States and 72 other locations
The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...
Phase 3
Dallas, Texas, United States and 122 other locations
and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...
Phase 2
McKinney, Texas, United States of America and 24 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
McKinney, Texas, United States and 65 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Dallas, Texas, United States and 335 other locations
This Phase 2b open-label, long-term extension study is designed to evaluate the long-term safety and efficacy of KT-621 in participants with asthma...
Phase 2
Dallas, Texas, United States and 6 other locations
Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...
Phase 3
McKinney, Texas, United States and 49 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Dallas, Texas, United States and 146 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
Dallas, Texas, United States and 70 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Dallas, Texas, United States of America and 101 other locations
Clinical trials
Research sites
Resources
Legal